首页> 美国卫生研究院文献>other >Sustained effect of glucagon on body weight and blood glucose: Assessed by continuous glucose monitoring in diabetic rats
【2h】

Sustained effect of glucagon on body weight and blood glucose: Assessed by continuous glucose monitoring in diabetic rats

机译:胰高血糖素对体重和血糖的持续作用:通过持续监测糖尿病大鼠的血糖来评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Insulin is a vital part of diabetes treatment, whereas glucagon is primarily used to treat insulin-induced hypoglycemia. However, glucagon is suggested to have a central role in the regulation of body weight, which would be beneficial for diabetic patients. Since the glucagon effect on blood glucose is known to be transient, it is relevant to investigate the pharmacodynamics of glucagon after repeated dosing. In the present study, we used telemetry to continuously measure blood glucose in streptozotocin induced diabetic Sprague-Dawley rats. This allowed for a more detailed analysis of glucose regulation compared to intermittent blood sampling. In particular, we evaluated the blood glucose-lowering effect of different insulin doses alone, and in combination with a long acting glucagon analog (LAG). We showed how the effect of the LAG accumulated and persisted over time. Furthermore, we found that addition of the LAG decreased body weight without affecting food intake.In a subsequent study, we focused on the glucagon effect on body weight and food intake during equal glycemic control. In order to obtain comparable maximum blood glucose lowering effect to insulin alone, the insulin dose had to be increased four times in combination with 1 nmol/kg of the LAG. In this set-up the LAG prevented further increase in body weight despite the four times higher insulin-dose. However, the body composition was changed. The insulin group increased both lean and fat mass, whereas the group receiving four times insulin in combination with the LAG only significantly increased the fat mass. No differences were observed in food intake, suggesting a direct effect on energy expenditure by glucagon. Surprisingly, we observed decreased levels of FGF21 in plasma compared to insulin treatment alone. With the combination of insulin and the LAG the blood glucose-lowering effect of insulin was prolonged, which could potentially be beneficial in diabetes treatment.
机译:胰岛素是糖尿病治疗的重要组成部分,而胰高血糖素则主要用于治疗胰岛素引起的低血糖症。然而,胰高血糖素被建议在体重调节中起中心作用,这对糖尿病患者将是有益的。由于已知胰高血糖素对血糖的作用是短暂的,因此研究重复给药后胰高血糖素的药效学很重要。在本研究中,我们使用遥测法连续测量链脲佐菌素诱发的糖尿病Sprague-Dawley大鼠的血糖。与间歇性采血相比,这可以对葡萄糖调节进行更详细的分析。特别是,我们评估了单独使用不同剂量的胰岛素以及与长效胰高血糖素类似物(LAG)联合使用可降低血糖的作用。我们展示了LAG的影响是如何随着时间累积和持续的。此外,我们发现添加LAG可以减轻体重而又不影响食物摄入量。在随后的研究中,我们集中研究了胰高血糖素对等血糖控制过程中体重和食物摄入量的影响。为了获得与单独使用胰岛素相当的最大血糖降低效果,必须将胰岛素剂量与1 nmol / kg的LAG组合增加四倍。在这种设置中,尽管胰岛素剂量高出四倍,但LAG仍阻止了体重的进一步增加。但是,身体组成发生了变化。胰岛素组增加了瘦体重和脂肪质量,而接受四倍胰岛素与LAG组合的组仅显着增加了脂肪质量。食物摄入量未见差异,表明胰高血糖素对能量消耗有直接影响。令人惊讶地,我们观察到与单独的胰岛素治疗相比,血浆中FGF21的水平降低。通过将胰岛素和LAG结合使用,可以延长胰岛素的降血糖作用,这可能对糖尿病的治疗有益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号